Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma.

Gressin R, Daguindau N, Tempescul A, Moreau A, Carras S, Tchernonog E, Schmitt A, Houot R, Dartigeas C, Pignon JM, Corm S, Banos A, Mounier C, Dupuis J, Macro M, Fleury J, Jardin F, Sarkozy C, Damaj G, Feugier P, Fornecker LM, Chabrot C, Dorvaux V, Bouadallah K, Amorin S, Garidi R, Voillat L, Joly B, Celigny PS, Morineau N, Moles MP, Zerazhi H, Fontan J, Arkam Y, Alexis M, Delwail V, Vilque JP, Ysebaert L, Le Gouill S, Callanan MB; Lymphoma Study Association.

Haematologica. 2019 Jan;104(1):138-146. doi: 10.3324/haematol.2018.191429. Epub 2018 Aug 31.

2.

[Recurrent flush in a 70-year-old man].

Seneschal C, Garidi R, Coppin C, Khentache R, Belkhir F, Brihaye B, Melboucy-Belkhir S, Sené T.

Rev Med Interne. 2017 Jul;38(7):488-490. doi: 10.1016/j.revmed.2017.04.003. Epub 2017 May 3. French. No abstract available.

PMID:
28477949
3.

Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study.

Reboursiere E, Le Bras F, Herbaux C, Gyan E, Clavert A, Morschhauser F, Malak S, Sibon D, Broussais F, Braun T, Fornecker LM, Garidi R, Tricot S, Houot R, Joly B, Abarah W, Choufi B, Pham AD, Gac AC, Fruchart C, Marin E, Safar V, Parcelier A, Maisonneuve H, Bachy E, Cartron G, Jaccard A, Tournilhac O, Rossi C, Schirmer L, Martignoles JA, Gaulard P, Tilly H, Damaj G; From the Lymphoma Study Association (LYSA) centers.

Oncotarget. 2016 Dec 20;7(51):85573-85583. doi: 10.18632/oncotarget.10764.

4.

Does bendamustine impact the mobilization of peripheral blood stem cells? A multicenter retrospective study of 23 cases.

Gac AC, Azar N, Daguindau E, Cartron G, Fornecker LM, Gyan E, Broussais-Guillaumot F, Garidi R, Choufi B, Chantepie SP, Béné MC, Guiéze R, Bijou F, Gressin R, Amorim S, Damaj G.

Leuk Lymphoma. 2016 May;57(5):1149-53. doi: 10.3109/10428194.2016.1140160. Epub 2016 Feb 15.

PMID:
26879408
5.

Concomitant systemic and central nervous system non-Hodgkin lymphoma: the role of consolidation in terms of high dose therapy and autologous stem cell transplantation. A 60-case retrospective study from LYSA and the LOC network.

Damaj G, Ivanoff S, Coso D, Ysaebert L, Choquet S, Houillier C, Parcelier A, Abarah W, Marjanovic Z, Gressin R, Garidi R, Diouf M, Gac AC, Dupuis J, Troussard X, Morschhauseur F, Ghesquières H, Soussain C; LYSA and LOC network, France.

Haematologica. 2015 Sep;100(9):1199-206. doi: 10.3324/haematol.2015.126110. Epub 2015 Jul 16.

6.

Results of a Prospective Study of High-Dose or Conventional Anthracycline-Cyclophosphamide Regimen Plus Radiotherapy for Localized Adult Non-Hodgkin's Primary Bone Lymphoma.

Schmidt-Tanguy A, Houot R, Lissandre S, Abgrall JF, Casassus P, Rodon P, Desablens B, Marolleau JP, Garidi R, Lamy T, Moles-Moreau MP, Damaj G.

Adv Hematol. 2014;2014:512508. doi: 10.1155/2014/512508. Epub 2014 Mar 2.

7.

ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.

Damaj G, Joris M, Chandesris O, Hanssens K, Soucie E, Canioni D, Kolb B, Durieu I, Gyan E, Livideanu C, Chèze S, Diouf M, Garidi R, Georgin-Lavialle S, Asnafi V, Lhermitte L, Lavigne C, Launay D, Arock M, Lortholary O, Dubreuil P, Hermine O.

PLoS One. 2014 Jan 21;9(1):e85362. doi: 10.1371/journal.pone.0085362. eCollection 2014.

8.

Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot study.

Paccou J, Merlusca L, Henry-Desailly I, Parcelier A, Gruson B, Royer B, Charbonnier A, Ursu D, Desailloud R, Garidi R, Kamel S, Sevestre H, Marolleau JP, Fardellone P, Damaj G.

Ann Oncol. 2014 Feb;25(2):481-6. doi: 10.1093/annonc/mdt560. Epub 2014 Jan 8.

PMID:
24401926
9.

Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy.

Gruson B, Ghomari K, Beaumont M, Garidi R, Just A, Merle P, Merlusca L, Marolleau JP, Royer B.

J Peripher Nerv Syst. 2011 Sep;16(3):180-5. doi: 10.1111/j.1529-8027.2011.00343.x.

PMID:
22003932
10.

Efficacy of bendamustine in relapsed/refractory myeloma patients: results from the French compassionate use program.

Damaj G, Malard F, Hulin C, Caillot D, Garidi R, Royer B, Marit G, Stoppa AM, Banos A, Morineau N, Moreau P, Fitoussi O, Tiab M, Moreau P.

Leuk Lymphoma. 2012 Apr;53(4):632-4. doi: 10.3109/10428194.2011.622422. Epub 2011 Nov 25.

PMID:
21916831
11.

[Iatrogenic pulmonary necrosis due to hyperselective chemotherapy].

Vanelslander P, Richard S, Bouguerrouche Y, Bouketouche M, Youssef A, Kanaan M, Berna P, Douadi Y, Garidi R, Dayen C.

Rev Mal Respir. 2011 Jan;28(1):66-70. doi: 10.1016/j.rmr.2010.04.018. Epub 2011 Jan 13. French.

PMID:
21277476
12.

Bronchial fistula associated with sunitinib in a patient previously treated with radiation therapy.

Basille D, Andrejak M, Bentayeb H, Kanaan M, Fournier C, Lecuyer E, Boutemy M, Garidi R, Douadi Y, Dayen C.

Ann Pharmacother. 2010 Feb;44(2):383-6. doi: 10.1345/aph.1M469. Epub 2010 Jan 5.

PMID:
20118139
13.

Myelofibrosis-associated lymphoproliferative disease: retrospective study of 16 cases and literature review.

Etienne A, Gruson B, Chatelain D, Garidi R, Royer B, Sevestre H, Marolleau JP, Damaj G.

Adv Hematol. 2009;2009:179847. doi: 10.1155/2009/179847. Epub 2009 Nov 25.

14.

Tyrosine kinase inhibitors and solid tumours: case report and review of the literature.

Roszkiewicz F, Garidi R, Vaida I, Royer B, Parcelier A, Marolleau JP, Damaj G.

Pharmacology. 2009;84(1):38-41. doi: 10.1159/000225970. Epub 2009 Jun 23. Review.

PMID:
19546604
15.

Thrombocytopenia in sarcoidosis.

Mahévas M, Le Page L, Salle V, Lescure FX, Smail A, Cevallos R, Garidi R, Marolleau JP, Duhaut P, Ducroix JP.

Sarcoidosis Vasc Diffuse Lung Dis. 2006 Oct;23(3):229-35. Review.

PMID:
18038923
16.

Multi-drug resistance mediated by P-glycoprotein overexpression is not correlated with ZAP-70/CD38 expression in B-cell chronic lymphocytic leukemia.

Guillaume N, Gouilleux-Gruart V, Claisse JF, Troussard X, Lepelley P, Damaj G, Royer B, Garidi R, Lefrere JJ.

Leuk Lymphoma. 2007 Aug;48(8):1556-60.

PMID:
17701587
17.

Treatment of severe autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab.

Royer B, Vaida I, Etienne A, Garidi R, Damaj G, Marolleau JP.

Leukemia. 2007 Aug;21(8):1841-2; author reply 1842-3. Epub 2007 Apr 26. No abstract available.

PMID:
17460703
18.

First-line autologous stem cell transplantation in primary CNS lymphoma.

Brevet M, Garidi R, Gruson B, Royer B, Vaida I, Damaj G.

Eur J Haematol. 2005 Oct;75(4):288-92.

PMID:
16146534
19.

Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial.

Hunault M, Harousseau JL, Delain M, Truchan-Graczyk M, Cahn JY, Witz F, Lamy T, Pignon B, Jouet JP, Garidi R, Caillot D, Berthou C, Guyotat D, Sadoun A, Sotto JJ, Lioure B, Casassus P, Solal-Celigny P, Stalnikiewicz L, Audhuy B, Blanchet O, Baranger L, Béné MC, Ifrah N; GOELAMS (Groupe Ouest-Est des Leucémies Airguës et Maladies du Sang) Group.

Blood. 2004 Nov 15;104(10):3028-37. Epub 2004 Jul 15.

20.

Opportunistic infection with Rhodotorula in cancer patients treated by chemotherapy: two case reports.

Alliot C, Desablens B, Garidi R, Tabuteau S.

Clin Oncol (R Coll Radiol). 2000;12(2):115-7.

PMID:
10853751

Supplemental Content

Loading ...
Support Center